The point was actually just to show that multiple treatment protocols can have quite dramatic results when you just look at some case studies.
For example one competitor has a case study available where patient improved from MMSE score 0-2 to 12. Quite remarkable improvement don't you think. But it was still just one patient just like Anavex has some.